-+ 0.00%
-+ 0.00%
-+ 0.00%

CHANNEL THERAPEUTICS CORP - LIGAND IS ENTITLED TO A 13% ROYALTY ON WORLDWIDE SALES OF ZELSUVMI

Reuters·04/17/2025 10:00:42

Please log in to view news